SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-012517
Filing Date
2021-03-11
Accepted
2021-03-11 16:15:26
Documents
3
Period of Report
2021-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - 4Q2020 evok-8k_20210311.htm 8-K 35191
2 EX-99.1 evok-ex991_8.htm EX-99.1 229240
3 GRAPHIC gtptffpnpbxp000001.jpg GRAPHIC 18169
  Complete submission text file 0001564590-21-012517.txt   290737
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 21733467
SIC: 2834 Pharmaceutical Preparations